The Origins of Chromosomal Instability in Human Tumor Cells

人类肿瘤细胞染色体不稳定性的起源

基本信息

  • 批准号:
    8680027
  • 负责人:
  • 金额:
    $ 35.02万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-07-01 至 2016-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Many human tumor cells are chromosomally unstable, showing an elevated rate of gains and losses of whole chromosomes that is 10-100 times higher than that seen in diploid primary cells. Chromosome instability (CIN) enhances the evolution of tumor cells causing genomic changes that can promote metastasis and chemotherapeutic resistance. CIN can have a causal role in tumorigenesis and it correlates with poor patient prognosis. Identifying the mutations that cause CIN in human cancer, and understanding why they reduce the fidelity of mitosis, are important objectives in cancer research. The inactivation of the pRB pathway promotes cell proliferation and is a common event in tumor cells. Interestingly, the functional inactivation of pRB causes aneuploidy. Recent experiments show that the specific loss of pRB increases rates of chromosome mis-segregation to levels that are remarkably similar to CIN tumor cells. This strongly suggests that a significant fraction of the chromosome instability seen in tumor cells is a byproduct of the inactivation of pRB. This grant investigates the exciting link between pRB inactivation and chromosome mis-segregation. Newly obtained results show that the loss of pRB causes defects in centromere function and chromatid cohesion. We will test the hypothesis that defects in cohesion and condensation allow chromosome mis-segregation when pRB-deficient cells are delayed in mitosis. Cohesin is the primary determinant of chromosome cohesion. In Aim 1 we will determine how the association of cohesin complexes with chromatin is altered in the absence pRB, and will test the functional significance of physical interactions between pRB and cohesin. The experiments in Aim 2 will test whether the mitotic defects in pRB-deficient cells can be either suppressed or enhanced. Such experiments may lead to new therapeutic opportunities. In Aim 3 we will extend these studies to cancer cells and will measure and compare the changes in centromere function, chromosome cohesion, and the rates of chromosome mis-segregation seen when functional pRB is re-introduced into tumor cells that lack it, or is specifically removed from tumor cells with functional pRB. We will determine whether similar changes occur when pRB is inactivated by deregulated cdk activity and when pRB-related proteins are targeted.
描述(由申请人提供):许多人类肿瘤细胞在染色体上是不稳定的,显示出整个染色体的获得和丢失率比二倍体原代细胞高10-100倍。染色体不稳定性(CIN)促进肿瘤细胞的进化,导致基因组变化,从而促进肿瘤转移和化疗耐药。CIN可能在肿瘤发生中起因果作用,并与患者预后不良相关。确定在人类癌症中引起CIN的突变,并理解它们为什么会降低有丝分裂的保真度,是癌症研究的重要目标。pRB通路的失活促进细胞增殖,是肿瘤细胞中常见的事件。有趣的是,pRB的功能失活导致非整倍体。最近的实验表明,pRB的特异性缺失增加了染色体错分离率,其水平与CIN肿瘤细胞非常相似。这有力地表明,在肿瘤细胞中看到的染色体不稳定性的很大一部分是pRB失活的副产品。这项资助研究了pRB失活和染色体错误分离之间令人兴奋的联系。新获得的结果表明,pRB的缺失导致着丝粒功能和染色单体内聚的缺陷。我们将验证当prb缺陷细胞在有丝分裂中延迟时,内聚和凝聚缺陷允许染色体错误分离的假设。内聚蛋白是染色体内聚的主要决定因素。在Aim 1中,我们将确定在缺乏pRB的情况下,黏结蛋白复合物与染色质的关联是如何改变的,并将测试pRB和黏结蛋白之间物理相互作用的功能意义。Aim 2的实验将测试prb缺陷细胞的有丝分裂缺陷是否可以被抑制或增强。这样的实验可能会带来新的治疗机会。在Aim 3中,我们将把这些研究扩展到癌细胞,并将测量和比较着丝粒功能、染色体内聚和染色体错分离率的变化,当将功能性pRB重新引入缺乏它的肿瘤细胞或特异性地从具有功能性pRB的肿瘤细胞中移除时,可以看到。我们将确定当pRB因cdk活性失调而失活时,以及当pRB相关蛋白被靶向时,是否会发生类似的变化。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NICHOLAS J DYSON其他文献

NICHOLAS J DYSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NICHOLAS J DYSON', 18)}}的其他基金

Using patient-derived models to understand drug responses in SCLC
使用源自患者的模型来了解 SCLC 的药物反应
  • 批准号:
    10456908
  • 财政年份:
    2018
  • 资助金额:
    $ 35.02万
  • 项目类别:
Using patient-derived models to understand drug responses in SCLC
使用源自患者的模型来了解 SCLC 的药物反应
  • 批准号:
    10247067
  • 财政年份:
    2018
  • 资助金额:
    $ 35.02万
  • 项目类别:
Deciphering the code of RB phosphorylation
破译RB磷酸化密码
  • 批准号:
    10413105
  • 财政年份:
    2018
  • 资助金额:
    $ 35.02万
  • 项目类别:
Deciphering the code of RB phosphorylation
破译RB磷酸化密码
  • 批准号:
    10187530
  • 财政年份:
    2018
  • 资助金额:
    $ 35.02万
  • 项目类别:
Dissection and manipulation of RB function
RB 函数的剖析和操作
  • 批准号:
    9107393
  • 财政年份:
    2012
  • 资助金额:
    $ 35.02万
  • 项目类别:
Dissection and manipulation of RB function
RB 函数的剖析和操作
  • 批准号:
    8439189
  • 财政年份:
    2012
  • 资助金额:
    $ 35.02万
  • 项目类别:
Dissection and manipulation of RB function
RB 函数的剖析和操作
  • 批准号:
    8699509
  • 财政年份:
    2012
  • 资助金额:
    $ 35.02万
  • 项目类别:
Dissection and manipulation of RB function
RB 函数的剖析和操作
  • 批准号:
    8551640
  • 财政年份:
    2012
  • 资助金额:
    $ 35.02万
  • 项目类别:
Dissection and manipulation of RB function
RB 函数的剖析和操作
  • 批准号:
    8878199
  • 财政年份:
    2012
  • 资助金额:
    $ 35.02万
  • 项目类别:
The Origins of Chromosomal Instability in Human Tumor Cells
人类肿瘤细胞染色体不稳定性的起源
  • 批准号:
    8294605
  • 财政年份:
    2011
  • 资助金额:
    $ 35.02万
  • 项目类别:

相似海外基金

Elucidating the effects of extra chromosome elimination in mosaic aneuploidy syndromes: Pallister-Killian syndrome as a model
阐明额外染色体消除对嵌合非整倍体综合征的影响:以 Pallister-Killian 综合征为模型
  • 批准号:
    10887038
  • 财政年份:
    2023
  • 资助金额:
    $ 35.02万
  • 项目类别:
Characterization of aneuploidy, cell fate and mosaicism in early development
早期发育中非整倍性、细胞命运和嵌合体的表征
  • 批准号:
    10877239
  • 财政年份:
    2023
  • 资助金额:
    $ 35.02万
  • 项目类别:
The impact of aneuploidy on early human development
非整倍体对人类早期发育的影响
  • 批准号:
    MR/X007979/1
  • 财政年份:
    2023
  • 资助金额:
    $ 35.02万
  • 项目类别:
    Research Grant
Cell competition, aneuploidy, and aging
细胞竞争、非整倍性和衰老
  • 批准号:
    10648670
  • 财政年份:
    2023
  • 资助金额:
    $ 35.02万
  • 项目类别:
Understanding how aneuploidy disrupts quiescence in the model eukaryote Saccharomyces cerevisiae
了解非整倍体如何破坏模型真核生物酿酒酵母的静止状态
  • 批准号:
    10735074
  • 财政年份:
    2023
  • 资助金额:
    $ 35.02万
  • 项目类别:
Preventing Age-Associated Oocyte Aneuploidy: Mechanisms Behind the Drosophila melanogaster Centromere Effect
预防与年龄相关的卵母细胞非整倍性:果蝇着丝粒效应背后的机制
  • 批准号:
    10538074
  • 财政年份:
    2022
  • 资助金额:
    $ 35.02万
  • 项目类别:
Functional evaluation of kinesin gene variants associated with female subfertility and egg aneuploidy.
与女性生育力低下和卵子非整倍性相关的驱动蛋白基因变异的功能评估。
  • 批准号:
    10537275
  • 财政年份:
    2022
  • 资助金额:
    $ 35.02万
  • 项目类别:
Using CRISPR screening to uncover aneuploidy-specific genetic dependencies
使用 CRISPR 筛选揭示非整倍体特异性遗传依赖性
  • 批准号:
    10661533
  • 财政年份:
    2022
  • 资助金额:
    $ 35.02万
  • 项目类别:
Comparative Analysis of Aneuploidy and Cellular Fragmentation Dynamics in Mammalian Embryos
哺乳动物胚胎非整倍性和细胞破碎动力学的比较分析
  • 批准号:
    10366610
  • 财政年份:
    2022
  • 资助金额:
    $ 35.02万
  • 项目类别:
FASEB SRC: The Consequences of Aneuploidy: Honoring the Contributions of Angelika Amon
FASEB SRC:非整倍体的后果:纪念 Angelika Amon 的贡献
  • 批准号:
    10467260
  • 财政年份:
    2022
  • 资助金额:
    $ 35.02万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了